JP Morgan Downgrades Definitive Healthcare to Underweight, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anne Samuel has downgraded Definitive Healthcare (NASDAQ:DH) from Neutral to Underweight and lowered the price target from $7 to $5.
July 31, 2024 | 11:22 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan analyst Anne Samuel downgraded Definitive Healthcare from Neutral to Underweight and reduced the price target from $7 to $5.
The downgrade from Neutral to Underweight and the reduction in the price target from $7 to $5 by a major financial institution like JP Morgan is likely to negatively impact investor sentiment and the stock price of Definitive Healthcare in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100